Migraines

Patients who suffer from migraines frequently cite inconsistent effectiveness as a reason for their dissatisfaction with their medicine. New data from more than 1,100 patients show that the investigational migraine therapy Trexima, when taken early, produced pain-free results at two and four hours, as well as a sustained pain- free response 2-24 hours, across individual patients’ multiple migraine attacks, demonstrating the consistency in efficacy that patients desire. [click link for full article]

More: continued here